Therefore, we anticipate that the uptake of Tat-Hsp27 into the brain will readily occur when nasally administered and will protect against cell death caused by hyperphosphorylated tau, which is one of the primary causes of AD (Brasnjevic et al. 2009; Schwarze et al. 1999). This evidence concerns the gene MAPT and Alzheimer disease.